0001193125-26-187155
SEC filingHCA Healthcare, Inc. held its Annual Meeting of Stockholders on April 23, 2026, where nine director nominees were elected and proposals on auditor ratification, executive compensation advisory vote, and two stockholder proposals were voted upon, with the latter two failing to achieve majority support.
The Annual Meeting results reflect broad shareholder support for HCA’s current governance structure and executive compensation framework, as evidenced by the approval of all director nominees and the advisory say-on-pay resolution. The overwhelming ratification of Ernst & Young LLP underscores continued confidence in financial reporting integrity. However, the decisive rejection of two stockholder proposals — one seeking disclosure on healthcare consequences and another aiming to restore shareholders’ right to act by written consent — signals limited appetite among voting shareholders for expanding ESG-related reporting mandates or altering corporate governance mechanics. Broker non-votes were consistently high (14.3M) for proposals requiring discretionary voting, particularly those not recommended by management, reinforcing the influence of proxy advisors and institutional voting policies. With no contested director elections or adverse voting outcomes on core governance matters, the meeting affirms stability in board leadership and audit oversight, though the low support for the healthcare consequences proposal may warrant attention given increasing investor focus on social impact metrics in healthcare.